IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production
Bradda Head Lithium exceeds targets, secures US$3 million royalty and moves closer to productionView Video
IntelliAM aiming for significant growth with £5 million Aquis IPO
IntelliAM aiming for significant growth with £5 million Aquis IPOView Video

Latest Share Chat

Pin to quick picksSanofi Share News (SAN.PA)

Share Price Information for Sanofi (SAN.PA)

Euronext Paris
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 90.94
Bid: 90.92
Ask: 90.94
Change: 0.71 (0.787%)
Spread: 0.02 (0.022%)
Open: 91.24
High: 91.26
Low: 90.80
Prev. Close: 90.23
SAN.PA Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

British equities slip on higher yields, financials drag

Tue, 02nd Jan 2024 17:05

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Marks and Spencer rises on ratings upgrade

*

AstraZeneca up as RSV infant shots approved in China

*

UK factory revival prospects suffer setback in Dec

Jan 2 (Reuters) - London stocks started the year on a sombre note, weighed down by losses in the financial sector and as UK government bond yields climbed to two-weeks high.

The blue-chip FTSE 100 fell 0.2% on Tuesday, after hitting an over seven-month high earlier in the session, while the mid-cap FTSE 250 index was down 0.9%.

Yields on the benchmark 10-year government bond rose over 15 basis points to 3.695%, touching a more than two-week high, tracking moves in U.S. Treasuries as investors moved away from higher risk assets.

The investment banking and brokerage services index led the losses with a 2.2% fall, closely followed by a 1.9% decline in life insurance stocks.

Meanwhile, the FTSE 100 completed its 40th trading year.

"The headline index has made almost no progress since the start of the century, and in the last decade the Footsie has been totally eclipsed by the U.S. stock market," said Laith Khalaf, head of investment analysis at AJ Bell.

Top performer pharma and biotech shares jumped 1.7%, supported by a 1.8% rise in AstraZeneca after the drugmaker's respiratory syncytial virus (RSV) immunisation for infants developed with Sanofi got approval in China.

Oil and gas shares added 0.4% as crude prices moved higher on the prospect of Middle Eastern supply disruptions after a naval clash in the Red Sea.

"Fundamentally, while supply continues to outstrip demand, the escalating hostilities in the Red Sea are raising concerns and providing support," said David Morrison, senior market analyst at Trade Nation.

Among individual movers, Marks and Spencer advanced 1.3% after Exane BNP Paribas raised the retailer's stock rating to "outperform" from "neutral".

Britain's manufacturing sector suffered a setback in its recovery efforts as output and employment fell more sharply in December than in the previous month, according to a survey.

Another set of data showed prices charged by British store chains rose at the slowest pace in a year and a half in December, an industry group said. (Reporting by Khushi Singh, Shubham Batra and Shashwat Chauhan in Bengaluru; Editing by Shinjini Ganguli and Mark Potter)

More News
12 Dec 2022 21:46

Amgen dives deeper into rare disease drugs with $27.8 bln Horizon deal

Dec 12 (Reuters) - Amgen Inc on Monday agreed to buy Horizon Therapeutics Plc in a deal valued at $27.8 billion, fortifying its rare diseases portfolio in the biggest buyout in the sector this year.

Read more
12 Dec 2022 17:26

European shares slip on fears over rising China COVID cases, await rate decisions

STOXX 600 down 0.5%

*

Read more
12 Dec 2022 11:25

Three-way split coming at BoE

STOXX down 0.4%, volatility hits 1-mo high

*

Read more
12 Dec 2022 10:48

What to prefer in 2023: Europe or America?

STOXX down 0.4%, volatility hits 1-mo high

*

Read more
12 Dec 2022 07:44

Europe seen weaker as more rate hikes loom

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

Read more
12 Dec 2022 06:59

Hunkering down

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

Read more
7 Dec 2022 17:43

European shares fall for fourth day on growth worries

STOXX 600 falls for the fourth straight day

*

Read more
7 Dec 2022 12:16

GSK, Sanofi shares soar as Zantac litigation fears abate

Thousands of Zantac lawsuits dismissed on Tuesday

*

Read more
7 Dec 2022 11:43

Winter is coming... and so are earnings downgrades

STOXX 600 falls 0.5%

*

Read more
7 Dec 2022 11:22

Being bearish but also bullish on Europe Inc

STOXX 600 down 0.5%

*

Read more
7 Dec 2022 09:24

Forza Italia in early Europe

STOXX 600 down 0.2%

*

Read more
7 Dec 2022 08:09

Sanofi shares rally as company avoids U.S. lawsuits over Zantac

PARIS, Dec 7 (Reuters) - Sanofi shares rose by around 8% in early Paris stockmarket trading on Wednesday after the company avoided thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer.

Read more
6 Dec 2022 23:12

GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link

Dec 6 (Reuters) - Drugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science.

Read more
6 Dec 2022 19:51

GSK, Pfizer, Sanofi escape U.S. federal litigation over Zantac

Dec 6 (Reuters) - Drugmakers GSK Plc, Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday defeated thousands of lawsuits in U.S. federal court claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science.

Read more
2 Dec 2022 17:15

Europe's STOXX 600 slips, but marks seventh week of gains

Sanofi slips amid Horizon deal talks

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.